Cargando…
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
SIMPLE SUMMARY: Polymorphonuclear myeloid-derived suppressive cells (PMN-MDSCs) have been associated to bad prognosis and resistance to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma (MM). In this study, we describe an immature subset of PMN-MDSCs capable of a high cytotoxicity aga...
Autores principales: | Gondois-Rey, Françoise, Paul, Magali, Alcaraz, Florence, Bourass, Sarah, Monnier, Jilliana, Malissen, Nausicaa, Grob, Jean-Jacques, Bruger, Annika M., Van Der Bruggen, Pierre, Gaudy-Marqueste, Caroline, Olive, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002694/ https://www.ncbi.nlm.nih.gov/pubmed/33802925 http://dx.doi.org/10.3390/cancers13061362 |
Ejemplares similares
-
MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
por: Vanhaver, Christophe, et al.
Publicado: (2021) -
CD47-SIRPα Controls ADCC Killing of Primary T Cells by PMN Through a Combination of Trogocytosis and NADPH Oxidase Activation
por: Gondois-Rey, Françoise, et al.
Publicado: (2022) -
Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population
por: Malissen, Nausicaa, et al.
Publicado: (2021) -
Early Phase of Primary Melanoma Growth from the Patient Point of View: A Prospective Cross Sectional Study on Melanoma over 1 mm in Thickness
por: MALISSEN, Nausicaa, et al.
Publicado: (2020) -
Stroke Exacerbates Cancer Progression by Upregulating LCN2 in PMN-MDSC
por: Huang, Tingting, et al.
Publicado: (2020)